Close Search

Products

Enter keywords

Related results

Peptide receptive HLA class I molecules allowing you to make your own custom peptide-HLA complexes.

HLA-A3101 easYmers®

Catalog no.
1032-01
Group
HLA-A
Alpha chain
HLA-A3101
Beta chain
b2m
Peptide
KVVNRWLFR
Peptide source
YFV NS5 376-384
Format
easYmer
Storage
-20°C
Buffer
TRIS/MALEATE pH 7
Shelf life
18 Months
Application
easYmers® are peptide receptive HLA class I molecules which can be used to generate peptide HLA (pHLA) monomers with your choice of peptide. The monomers can easily be tetramerized with fluorophore conjugated streptavidin and used to analyse T cells by flowcytometry. The easYmer reagent can also be used to evaluate specific pHLA I interactions.
Concentration
3000 nM
For Research Use Only (RUO)

Published Research using immunAware reagents and services

07/09/2024

bioRxiv : the preprint server for biology

Antigen-specificity of clonally-enriched CD8+ T cells in multiple sclerosis

CD8+ T cells are the dominant lymphocyte population in multiple sclerosis (MS) lesions where they are highly clonally expanded. The clonal identity, function, and antigen specificity of CD8+ T cells in MS are not well understood. Here we report a comprehensive single-cell RNA-seq and T cell receptor (TCR)-seq analysis of the cerebrospinal fluid (CSF) and blood from a cohort of treatment-naïve MS patients and control participants. A small subset of highly expanded and activated CSF-enriched CD8+ T cells were abundant in people with MS and displayed high cytotoxicity and tissue-homing transcriptional profiles. Using a combination of unbiased and targeted antigen discovery approaches, several MS-derived CD8+ T cell clonotypes recognizing Epstein-Barr virus (EBV) antigens and novel mimotopes were identified. These findings shed insight into the functions of CD8+ T cells in MS and may serve as potential disease biomarkers and therapeutic targets.